Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06585566
Recruiting Not applicable

Alveolar Cleft Reconstruction With Cortical-Shells

NCT06585566 · tracked via the Priya Life Science Egypt tracker
Sponsor
Beni-Suef University
Phase
Not applicable
Started
2024-10-04
Last updated
2025-01-22

Condition(s) studied

Alveolar Cleft

Investigational drug(s) / intervention(s)

Cortical-shell graft

Cortical-shell graft: Retromolar cortical shell graft technique for SABG

Study summary

The main goal of the secondary alveolar bone grafting (SABG) for alveolar clefts is the rehabilitation of the disorganized maxilla, aiming to stabilize the maxillary foundation as a solid functional mass that would abort growth disturbance, allow for teeth eruption, and enhance their orthodontic movements.

The study evaluates the outcomes of a ( SABG) technique that utilizes the retromolar cortical shell technique to reconstruct the alveolar clefts.

Eligibility

Sex
ALL
Min age
8 Years
Max age
15 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients of both sexes with an age range of (eight to fifteen years), with unilateral maxillary alveolar cleft. 2. good oral hygiene and general good health Exclusion Criteria: 1. The evidence of clinical or radiographic signs of local maxillary pathosis or palatal fistulae. 2. Those patients with bilateral alveolar clefts, cleft-associated syndromes, and those with a systemic disease that would affect either bone harvest or graft healing. 3. A history of previous failed alveolar cleft reconstruction.

Primary outcome measure(s)

  • Horizontal bone width — 6 months consolidation period
    The amplitude of radiographic horizontal bone width change

Trial sites (2)

FacilityCityRegionStatus
Amr Gibaly Cairo Egypt Recruiting
Department of Oral and Maxillofacial Surgery, Faculty of Oral and Dental Medicine, Modern University for Technology & Information. Cairo Egypt Recruiting

More Beni-Suef University trials in Egypt

Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality Recruiting
ComfiJ Versus Conventional Double-J Stent for Ureteral Stent Symptoms Recruiting
A Comparative Study of EMG Biofeedback and Pharmacotherapy for the Treatment of Masticatory Muscle Hyperactivity in Bruxism Patients Starting soon
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Recruiting
Bone Augmentation Using Calvarial Versus Iliac Crest Bone Blocks. Recruiting

Other trials for the same condition

Bilateral Alveolar Cleft Reconstruction Using Double Iliac Bone Blocks vs Particulate Grafting Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06585566 on ClinicalTrials.gov ↗ ← All trials in Egypt